FIELD: medicine, gastroenterology, therapy. SUBSTANCE: treatment is performed with the preparation derinat as 1.5% solution of deoxyribonucleic acid sodium salt in 0.1% sodium chloride solution. The preparation is administrated by an intramuscular route in a dose 5 ml every other day. Treatment course is 3-5 injections. Method ensures to carry out the sanation of stomach mucosa from Helicobacter pylori. Invention is designated for monotherapy of pyloric helicobacteriosis. EFFECT: enhanced effectiveness of therapy of ulcer disease. 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WITH STOMACH AND DUODENAL INTESTINE ULCER DISEASE | 1997 |
|
RU2155591C2 |
METHOD FOR HELICOBACTER PYLORI ERADICATION OF GASTRODUODENAL ZONE | 2014 |
|
RU2545687C1 |
METHOD OF TREATING PYLORIC HELICOBACTERIOSIS | 2012 |
|
RU2506076C1 |
METHOD OF SELECTION OF PHARMACOTHERAPY IN DUODENAL ULCERS | 1998 |
|
RU2145226C1 |
METHOD FOR PREDICTING THE EXACERBATIONS OF GASTRODUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2017 |
|
RU2664449C1 |
METHOD FOR TREATING GASTRIC AND DUODENAL PEPTIC ULCERS | 1999 |
|
RU2147877C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF GASTRODUODENAL ULCER | 2005 |
|
RU2295957C1 |
METHOD FOR ERADICATION OF GASTRIC AND DUODENAL HELICOBACTER PYLORI | 2006 |
|
RU2319523C2 |
DIAGNOSTIC TECHNIQUE FOR DEGREE OF ACTIVITY OF ANTRAL HELICOBACTER-ASSOCIATED GASTRITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2394499C1 |
METHOD FOR PREDICTING PYLORIC HELICOBACTERIOSIS | 2000 |
|
RU2194276C2 |
Authors
Dates
2002-07-27—Published
1997-04-21—Filed